Fatal Familial Insomnia

Fatal familial insomnia is a familial prion disease linked to a mutation of the prion protein gene. Here is the latest research on this rare genetic degenerative brain disorder.

October 24, 2021
Open Access

Defining the Prion Type of Fatal Familial Insomnia.

Pathogens
Wiebke Jürgens-WemheuerWalter Schulz-Schaeffer
October 21, 2021

Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions.

Journal of Neurology, Neurosurgery, and Psychiatry
Jing ZhangLi-Yong Wu
September 6, 2021
Case Report

Genetic Creutzfeldt-Jakob disease shows fatal family insomnia phenotype.

Prion
Bin ChenYong You
September 1, 2021
Case Report

Sporadic Creutzfeldt-Jakob Disease Appears to Be Sporadic Fatal Insomnia: A Case Report and Review of the Literature.

Nature and Science of Sleep
Qingqing SunLi Cui
July 30, 2021
Open Access

Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification.

Acta Neuropathologica
Simone BaiardiPiero Parchi
July 6, 2021
Open Access

Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementia.

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Andrea MastrangeloPiero Parchi
July 3, 2021
Review
Open Access

MicroRNAs in Prion Diseases-From Molecular Mechanisms to Insights in Translational Medicine.

Cells
Danyel Fernandes ContilianiTiago Campos Pereira
June 23, 2021
Case Report

Fatal insomnia: the elusive prion disease.

BMJ Case Reports
Dharmini PatelAdam Zeman
June 21, 2021

[Prion diseases or transmissible spongiform encephalopathies].

La Revue de médecine interne
J-P Brandel
June 9, 2021

Mediodorsal thalamus lesion increases paradoxical sleep in rats.

Sleep Science
S N SrijiHruda Nanda Mallick
May 18, 2021
Comment / Editorial
Open Access

JNO Literature Commentary.

Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
April 21, 2021
Open Access

TREM2 expression in the brain and biological fluids in prion diseases.

Acta Neuropathologica
Daniela Diaz-LucenaFranc Llorens
March 9, 2021
Open Access

Genetic prion disease: D178N with 129MV disease modifying polymorphism-a clinical phenotype.

BMJ Neurology Open
Tracie Huey-Lin TanMastura Monif
March 5, 2021
Open Access

Activation of Src family kinase ameliorates secretory trafficking in mutant prion protein cells.

The Journal of Biological Chemistry
Elena RestelliRoberto Chiesa
February 10, 2021

Clinical manifestations and polysomnography-based analysis in nine cases of probable sporadic Creutzfeldt-Jakob disease.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Yanyuan DaiLi Cui
February 4, 2021
Comment / Editorial
Open Access

Thirty years of fatal familial insomnia and autonomic research: celebrating the past, embracing the future.

Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
Pietro Cortelli

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/fatal-familial-insomnia/7d23898f-65ae-439d-9642-4d72967f10cc